In contrast, a study by Ma and colleagues found that, despite the activation of mTOR and its downstream signaling components, including 4E‐BP1 and S6K1 in invasive breast cancer, these markers did not exhibit a statistically significant correlation with prognosis20. This evidence concerns the gene MTOR and invasive breast carcinoma.